Journals / Turkish Neurosurgery / 2009 / Cilt: 19 - Sayı: 4

Rat spinal kord iskemi/reperfüzyon hasarı sonrası proinflamatuvar sitokin düzeyleri ve doku hasarı ile ilişkisi

Analysis of serum pro-Inflammatory cytokine levels after rat spinal cord ischemia/reperfusion injury and correlation with tissue damage

Pages
353–359
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Characterization of the role of inflammation in the etiopathogenesis of ischemia/reperfusion injury to the spinal cord is important to facilitate the development of novel therapeutic approaches for prevention and/or treatment of this severe condition.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: A rat model of spinal cord ischemia/reperfusion was conducted and the serum cytokine levels and histopathological changes were assessed.
📊
Key Findings & Data:Group-A (the sham operated rats) and group-B (the spinal ischemia/reperfusion group) were sacrificed at 24 hours postoperatively while group-C (the sham operated rats) and group-D (the spinal ischemia/reperfusion group) were sacrificed at 48 hours.
💡
Conclusion & Impact:Characterization of the role of inflammation in the etiopathogenesis of ischemia/reperfusion injury to the spinal cord is important to facilitate the development of novel therapeutic approaches for prevention and/or treatment of this severe condition.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: A rat model of spinal cord ischemia/reperfusion was conducted and the serum cytokine levels and histopathological changes were assessed. MATERIAL and METHODS: Twenty-four male Sprague-Dawley rats were assigned into four experimental groups. Group-A (the sham operated rats) and group-B (the spinal ischemia/reperfusion group) were sacrificed at 24 hours postoperatively while group-C (the sham operated rats) and group-D (the spinal ischemia/reperfusion group) were sacrificed at 48 hours. Histopathological changes in the spinal cords and serum cytokine levels were analysed. RESULTS: All three proinflammatory cytokine levels reached significantly higher levels compared to the sham operated groups in both the 24-hour and 48-hour spinal cord ischemia/reperfusion groups. CONCLUSION: Inflammation is a plausible pathway in spinal cord ishemia/reperfusion injury. However clinical treatment of the damage does not currently include antiinflammatory therapy. The results of our study supported the hypothesis that inflammatory responses could play a possible role in the ischemia/reperfusion injury of the spinal cord. Characterization of the role of inflammation in the etiopathogenesis of ischemia/reperfusion injury to the spinal cord is important to facilitate the development of novel therapeutic approaches for prevention and/or treatment of this severe condition.

Özet

AMAÇ: Rat spinal kord iskemi/reperfüzyon modeli oluşturuldu ve serum sitokin düzeyleri ve histopatolojik değişiklikler değerlendirildi. YÖNTEM ve GEREÇ: Yirmidört Sprague-Dawley rat dört deney grubuna ayrıldı. Grup A sham opereli ve Grup B spinal iskemi/reperfüzyon grubu ratlar postoperatif 24. saatte sakrifiye edildi. Grup C sham opereli ve Grup D spinal iskemi/reperfüzyon grubu ratlar postoperatif 48. saattte sakrifiye edildi. Spinal korddaki histopatolojik değişiklikler ve TNF- , IL-1ß ve IL-6 için serum sitokin düzeyleri incelendi. BULGULAR: Hem 24. saat, hem de 48. saat spinal kord iskemi/reperfüzyon gruplarında her üç proinflamatuvar sitokin düzeyleri sham opereli gruplarla karşılaştırıldığında belirgin olarak daha yüksek düzeylere eriştiler. SONUÇ: Spinal kord iskemi/reperfüzyon hasarında iflamasyon olası bir durumdur. Ancak hasarın klinik tedavisi günümüzde antiinflamatuvar tedaviyi içermemektedir. Bizim çalışmamızın sonuçları spinal kord iskemi/reperfüzyon hasarında inflamatuvar cevapların olası rol oynayabileceği hipotezini desteklemektedir. Spinal kordda iskemi/reperfüzyon hasarının etyopatogenezinde inflamasyonun rolünün tanımlanması bu ciddi durumun önlenmesi ve tedavisi için gelecek terapötik yaklaşımların gelişmesini kolaylaştırmada önemlidir.

🔖

Cite This Article

HASTURİK, A., ATALAY, B., ÇALIŞANELLER, T., ÖZDEMİR, Ö., ORUÇKAPTAN, H., ALTINÖRS, N. (2009). Rat spinal kord iskemi/reperfüzyon hasarı sonrası proinflamatuvar sitokin düzeyleri ve doku hasarı ile ilişkisi. Turkish Neurosurgery, Cilt: 19 - Sayı: 4, 353–359. https://ajindex.com/articles/405186

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Aloisi F, Borsellino G, Care A, Testa U, Gallo P, Russo G, Peschle C, Levi G: Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain. Int J Dev Neurosci 13:265-274, 1995 2. Bartholdi D, Schwab ME: Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: An in situ hybridization study. Eur J Neurosci 9:1422-1438, 1997 3. Bednar MM, Gross CE, Balazy M, Falck JR: Antineutrophil strategies. Neurology 49: 20-22, 1997 4. Boyle EM, Pohlman TH, Cornejo CJ, Verrier ED: Ischemiareperfusion injury. Ann Thorac Surg 64:24-30, 1997 5. Bradbury AW, Murie JA, Ruckley CV: Role of the leucocyte in the pathogenesis of vascular disease. Br J Surg 80:1503-1512, 1993 6. Clark WM, Madden KP, Rothlein R, Zivin JA: Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J Neurosurg 75:623-627, 1991 7. Coskun K, Attar A, Tuna H, Sargon MF, Yuceer N, Turker RK, Egemen N: Early protective effects of iloprost after experimental spinal cord ischemia in rabbits. Acta Neurochir (Wien) 142:1143-1150, 2000 8. Follis F, Scremin OU, Blisard KS, Scremin AM, Pett SB, Scott WJ, Kessler RM, Wernly JA: Selective vulnerability of white matter during spinal cord ischemia. J Cereb Blood Flow Metab 13:170-178, 1993 9. Gilling-Smith GL, Worswick L, Knight PF, Wolfe JH, Mansfield AO: Surgical repair of thoracoabdominal aortic aneurysm: 10 years' experience. Br J Surg 82:624-629, 1995 10. Giulian D, Robertson C: Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 27:33- 42, 1990 11. Hayashi M, Ueyama T, Nemoto K, Tamaki T, Senba E: Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 17:203-218, 2000 12. Hirose K, Okajima K, Taoka Y, Uchiba M, Tagami H, Nakano K, Utoh J, Okabe H, Kitamura N: Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg 232:272-280, 2000 13. Hofman FM, Hinton DR, Johnson K, Merrill JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607- 612, 1989 14. Jaeschke H: Preservation injury mechanisms, prevention and consequences: J Hepatol 25:774-780, 1996 15. Kanellopoulos GK, Kato H, Hsu CY, Kouchoukos NT: Spinal cord ischemic injury. Development of a new model in the rat. Stroke 28: 2532-2538, 1997 16. Klebanoff SJ, Vadas MA, Har